Mark Ballow, MD - PowerPoint PPT Presentation

1 / 42
About This Presentation
Title:

Mark Ballow, MD

Description:

Mark Ballow, MD. IgG subclass and Selective Antibody ... Immunology and Pediatric Rheumatology. Women and Children's Hospital of Buffalo. SUNY Buffalo ... – PowerPoint PPT presentation

Number of Views:25
Avg rating:3.0/5.0
Slides: 43
Provided by: wsa1
Category:

less

Transcript and Presenter's Notes

Title: Mark Ballow, MD


1
Mark Ballow, MD
2
IgG subclass and Selective Antibody Deficiency
Disorders
  • Mark Ballow, MD
  • Division of Allergy. Immunology and Pediatric
    Rheumatology
  • Women and Childrens Hospital of Buffalo
  • SUNY Buffalo
  • School of Medicine and Biomedical Sciences

3
Relative Distribution of the Primary
Immunodeficiencies
Complement Deficiency
Phagocytic
Cellular Deficiency
Antibody Deficiencies
Combined Immunodeficiency
4
Antibody Deficiency Disorders
  • Agammaglobulinemia with absent B-cells
  • Infantile x-linked (Brutons disease)
  • Tyrosine kinase deficiency
  • Defects of pre-B-cell receptor
  • Defects of B-cell signaling pathway
  • Transient hypogammaglobulinemia of infancy
  • Isolated immunoglobulin deficiency
  • IgA deficiency
  • IgM deficiency
  • X-linked and autosomal recessive forms of Hyper
    IgM Syndrome
  • Common variable immunodeficiency
  • ICOS deficiency
  • Diminished switched memory B-cells
  • TACI defects
  • IgG subclass deficiency
  • Selective antibody deficiency with normal
    immunoglobulins

5
What are the serum immunoglobulins and IgG
subclasses
6
Figure 4-18
7
The IgG subclass with the shortest half-life is
  • A. IgG1
  • B. IgG2
  • C. IgG3
  • D. IgG4

8
Figure 4-17 part 1 of 2
9
Which of the following IgG subclasses activates
complement the best?
  • A. IgG1
  • B. IgG2
  • C. IgG3
  • D. IgG4

10
Figure 4-17 part 2 of 2
11
Figure 11-11
12
Serum Immunoglobulin Levels
  • Age related differences are significant and must
    be considered for each evaluation
  • Normal range 95 confidence interval
  • Geometric mean 2 SD
  • Total immunoglobulin level is the net of
    production, consumption, and loss

13
Specific Antibody Response
Evaluate specific antibody response to protein
and carbohydrate by obtaining pre- and 4 week
post-immunization serum to evaluate antibody
response to the immunization
14
IgG Subclass Levels
  • Normal range varies
  • Varies with age-
  • IgG2 and IgG4 mature later than other IgG
    subclasses
  • Deficiency described statistically by normal
    distribution in the general population
  • 2 S.D. below the mean (average)
  • Antibodies to polysaccharide antigens are largely
    in the IgG2 subclass
  • These antibodies are not readily made until after
    age 2 unless given a conjugate vaccine, e.g.
    Prevnar, Hib

15
(No Transcript)
16
Evaluation of Possible Immunodeficiency
  • MUST BE BASED ON
  • Medical history of recurrent infections including
    frequency, site(s), therapy required
  • Family history of recurrent infections
  • Many PI are x-linked
  • Physical examination
  • Appropriate laboratory evaluation

17
Specific Antibody Responses
  • The standard in the evaluation of the B-cell
    immunity (humoral) is the capacity to mount a
    specific antibody response
  • Natural antibody screen
  • testing for isohemagglutinins (lt1yr unreliable)
  • Provocative testing immunization with protein
    and carbohydrate (polysaccharide) vaccines-
  • Tetanus toxoid
  • Pneumococcal polysaccharides
  • Pneumovax
  • Prevnar
  • neo-antigen FX - 174 antigen

18
Antibodies to pneumococcal polysaccharides fall
into which of the following IgG subclasses
  • A. IgG1
  • B. IgG2
  • C. IgG3
  • D. IgG4

19
The Biology of IgG Subclasses
Approximately 10 of individuals have absent IgG4
20
IgG Subclass Deficiency and Primary Immune
Deficiency
21
IgG2 and IgG4 deficiency is associated with which
of the following immune deficiencies
  • A. Wiskott-Aldrich disease
  • B. Severe Combined Immunodeficiency
  • C. Hyper IgM syndrome
  • D. IgA deficiency

22
IgG Subclass Deficiency in Immunodeficiency
Patients
  • IgG2 and IgG4 deficiency
  • IgA deficiency
  • Cartilage hair hypoplasia
  • Ataxia telangectasia
  • IgG3 deficiency
  • Wiskott-Aldrich Syndrome
  • Variable subclass deficiency
  • Common variable hypogammaglobulinemia

23
IgG Subclass Deficiency - Clinical Presentations
24
IgG Subclass deficiency and IgA Deficiency
  • Oxelius et al studied 37 IgA deficient patients
  • Seven of 37 had IgG2 deficiency
  • Patients with combined IgA-IgG2 deficiency had
    more severe and frequent lower respiratory tract
    infections
  • IgA deficiency is mostly partial
  • 15-18 IgG subclass deficiency
  • IgG2 deficiency often occurred with IgG4
    deficiency (6 of 7)

25
Recurrent sinopulmonary infections with selective
IgG2 subclass deficiency
  • Normal total serum IgG (20 patients)
  • IgG2/IgG3 subclass deficiency
  • 3/20 had IgA deficiency
  • Impaired antibody responses to bacterial capsular
    polysaccharide antigens
  • Hemophilus influenzae type b (Hib)

Umetsu et al N Eng J Med 1985
26
IgG subclass deficiency - the bigger picture
  • Shackelford et al (1990) screened normal blood
    donors and found individuals with IgG2 deficiency
    who were healthy
  • Subclass deficiency is a statistically derived
    value
  • By definition subclass deficiency 2 std
    deviations from the mean
  • Statistically - 2.5 of the general population
    will have low (2std) IgG subclass serum levels
  • Individuals with deletion of their heavy chain
    genes for the IgG subclasses without infection
  • Many of the children have a developmental lag
    in the maturation of their immune system

27
IgG subclass deficiency - the bigger picture
  • Controversy among clinical immunologists over
    measuring IgG subclasses
  • Real issue is to evaluate the ability to make
    specific antibodies
  • Protein antigens
  • Polysaccharide antigens

28
3 year old boy with a history of recurrent
sinusitis and pneumonias since age 18 months
  • History-
  • multiple ear infections until PE tubes placed at
    12 months of age
  • At 18 months of age started to have recurrent
    sinusitis
  • Several episodes of pneumonia
  • Family and social history
  • No allergies in family
  • No other children
  • No day care
  • No smoking

29
Screening of Immune Function
  • Screening Tests
  • Quantitative serum immunoglobulin (IgG, IgA, IgM)
    levels
  • IgG subclasses
  • Specific antibody responses
  • Protein antigens - tetanus
  • carbohydrate (polysaccharide) antigens

30
Immune testing results-
  • Normal serum immunoglobulins
  • Normal IgG subclasses
  • Good antibody production to tetanus, viral
    pathogens like RSV, influenza, and mycoplasma
  • Poor antibody production to pneumococcal
    polysaccharides despite immunizations with
    Pneumovax
  • Given one dose of Prevnar (conjugated
    pneumococcal vaccine) - still poor response

Diagnosis- Selective antibody deficiency
31
Recurrent infections and normal serum IgG
subclass levels with selective antibody responses
to polysaccharide antigens
  • Ambrosino et al
  • J Allergy Clin Immunol 1988

Specific antibody deficiency can be seen in 5-10
of children referred for the evaluation of
recurrent infections
32
Selective antibody deficiency
  • Antibody response to protein antigens such as
    tetanus usually normal
  • Potent antigen
  • Memory B-cells
  • Antibody responses to polysaccharide antigens
    poor
  • Less T-cell dependent
  • Antigen processing different

33
Figure 11-1 part 1 of 3
Significant pathogen for airway
infections 20-40 of otitis media 30-40 of
sinusitis 10-25 of pneumonia More than 50 of
S. pneumoniae isolates in the US have reduced
sensitivity to penicillin
34
Method for Evaluating a Specific Antibody
Response
  • Serum pre and 4 weeks following immunization
  • Testing the response to protein antigens (e.g.
    tetanus toxoid) is well established
  • Testing for carbohydrate (polysaccharide)
    antigens
  • Normal standards recently established
  • Age has a significant impact on response
  • New CDC assay standards improved testing

35
Pneumococcal vaccines
  • 23-valent polysaccharide vaccine
  • After age 24 months
  • Heptavalent conjugate vaccine
  • Immunogenic in infants
  • 4 doses
  • 2-5 yrs of age - one dose
  • Levels of protection
  • Invasive disease (hematogenous) - 0.15 µg/ml
  • Pneumonia - 1.3 µg/ml (200-300 ng Ab N/ml)

36
In a 30 month old child an adequate response to
Pneumovax should be
  • A. 25 of the 12 serotypes tested
  • B. 35 of the 12 serotypes tested
  • C. 50 of the 12 serotypes tested
  • D. 75 of the 12 serotypes tested

37
Percentage of patients in each age group and
their response to pneumococcal vaccine
9 serotypes tested of 23 valent vaccine
Sorensen et al JACI 98
38
Pneumococcal vaccines
  • Variables in response
  • Age - increase in response to greater number of
    serotypes
  • Age 2-5 - gt50 of serotypes
  • gt 5 yrs of age - 70-80 of serotypes
  • Vaccine/doses
  • Ethnicity
  • Persistence of antibody responses - immunologic
    amnesia

39
Treatment of IgG Subclass Deficiency and
Selective Antibody Deficiency
40
Treatment IgG Subclass Deficiency and Selective
Antibody Deficiencies
  • Prophylactic antibiotics
  • Sept. to May
  • Many of the children are atopic
  • Nasal steroids/decongestants
  • Environmental controls
  • ? IVIG therapy
  • 9 months of IVIG therapy
  • Re-vaccinate - 3-5 months off IVIG
  • If responds often sinusitis decreases

41
Therapy of IgG Subclass Deficiency with IVIG
  • Bjorkander et al (1985) - 4 patients with
    combined IgA and IgG2/4 deficiency
  • Geha et al (1987) - 12 patients with IgG2
    deficiency and recurrent sinopulmonary infections
  • 300-400 mg/kg IVIG every 3-4 weeks
  • Sinusitis decreased from 8.7 episodes / yr. to
    2.2 episodes per year
  • Pneumonia markedly decreased
  • Asthma - steroid sparing effect

42
Summary
  • Patients with a selective antibody deficiency
    to native polysaccharide antigens (pneumococcus)
    exist
  • Look for contributory factors
  • Allergy, smoking, day care, older sibs
  • Treatment-
  • Environmental intervention if atopic
  • Prophylactic antibiotics (Sept to May)
  • IGIV treatment - short term, e.g. 9 months
  • Outcomes
  • Many children outgrow this immune deficiency
  • A developmental lag in immune maturation
  • Adults may require long term IGIV therapy
Write a Comment
User Comments (0)
About PowerShow.com